Microglial regulation of white matter development and its disruption in autism spectrum disorder
Cerebral Cortex · 01.04.2025 · 35 (4)
DOI: 10.1093/cercor/bhaf109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cerebral Cortex, online erschienen am 30.04.2025. Verfasst von Katherine Canada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Virginia, Ivy Translational Research Building, 560 Ray C Hunt Drive, Charlottesville, VA 22903, United States. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, White Matter, Microglia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: NIMH NIH HHS, NINDS NIH HHS, National Institute of Mental Health and Neurosciences (NIMHANS).
Abstract (Originalsprache)
White matter, comprising approximately 50% of the human brain, is crucial for efficient neuronal signaling and a wide range of brain functions, including social cognition, sensation, memory, motor control, and information integration across cortical brain regions in the service of perception and cognition. White matter, composed of myelinated axons, results from complex interactions between different cell types, with oligodendrocytes (OLs) and microglia playing integral roles. Microglia, the brain's resident immune cells, regulate oligodendrogenesis through phagocytosis and molecular signaling, for example through cytokines, which promote and inhibit maturation stages of OL lineage cells. Maternal immune activation (MIA) is a recognized risk factor for neurodevelopmental disorders, especially autism spectrum disorder (ASD). The physiological presentation of ASD includes white matter abnormalities and immune dysregulation. Emerging evidence indicates that MIA may reduce microglial reactivity and alter cytokine release in offspring, potentially disrupting the delicate balance required for proper white matter development. Understanding the intricate interplay between oligodendrocytes, microglia, inflammation, and white matter development in the context of MIA provides valuable insights into the etiology of and core symptoms of ASD and possible therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of Virginia, Ivy Translational Research Building, 560 Ray C Hunt Drive, Charlottesville, VA 22903, United States.
- School of Education and Human Development, University of Virginia, Ridley Hall 126, PO Box 800784, 405 Emmet St S, Charlottesville, VA 22903, United States.
ORCID-Profile: Katherine Canada, Kevin A Pelphrey
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
- National Institute of Mental Health and Neurosciences (NIMHANS)
Zitieren
APA
Canada, K., Evans, T. M., & Pelphrey, K. A. (2025). Microglial regulation of white matter development and its disruption in autism spectrum disorder. Cerebral Cortex, 35(4). https://doi.org/10.1093/cercor/bhaf109
Vancouver
Canada K, Evans TM, Pelphrey KA. Microglial regulation of white matter development and its disruption in autism spectrum disorder. Cerebral Cortex. 2025;35(4). doi:10.1093/cercor/bhaf109
BibTeX
@article{Canada2025,
author = {Canada, Katherine and Evans, Tanya M and Pelphrey, Kevin A},
title = {Microglial regulation of white matter development and its disruption in autism spectrum disorder},
journal = {Cerebral Cortex},
year = {2025},
volume = {35},
number = {4},
doi = {10.1093/cercor/bhaf109}
}
EUVIMED